Methods of using morphogen analogs
US6110460A · kind A · utility
6Cited by
0References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 11, 1997 |
| Grant date | Aug 29, 2000 |
| Priority date | — |
| Expiry date | Jun 11, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods and compositions for identifying morphogen analogs. Preferred methods rest on the use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with a reporter gene. In certain embodiments, the methods involve an osteogenic protein 1 (OP-1) responsive transcription activating element. Substances that activate the OP-1 responsive transcription activating element are considered herein likely to be useful for reproducing in vivo effects of morphogens such as OP-1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.